Fantastic Article.... ....and why approval of AcuVid still has incredible potential.
The following opinion piece describes the reasons behind the shortfall in the availability of rapid antigen tests in the US. Written in the last 24 hours it also outlines how these tests continue to be readily available and used in many European countries. Clearly as supply is not yet meeting demand there is lots of opportunity for THRMs easy to use, accurate and inexpensive AcuVid to fill in the gap.
https://nymag.com/intelligencer/article/at-home-covid-tests-accuracy-supply-issues.html
Rob projected in the October NR that the completion of testing would take 2 to 3 weeks including a few days to receive IRB approval. As that took longer than expected it has been 9 days since approval was granted. The summary overview of the testing process suggested an end date sometime in December. That study sites have been organized suggests testing has probably already commenced.
Imho if testing is completed and FDA EUA is granted before Christmas THRM will easily see $1.00. If Rob can announce timing for production of tests and some initial contracts early in the new year it could become a 10x bagger (from its current sp) much sooner than expected.
From an accuracy perspective AcuVid has weathered all the challenges from new variants to increased expectations from the FDA. Hopefully this final roadblock meets with the same positive outcome.
GLTE ...holding patiently!!!